vision loss gene therapy (Vedere)

N/A

Report date: 2025/03/20 15:55:25

Base Information

Drug Namevision loss gene therapy (Vedere)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsVision Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVedere Bio II Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsVision Disorders

Inactive IndicationsN/A

ATC CodeN/A